Sacrococcygeal Teratomas in Currarino Syndrome: A Multicenter Review of Tumor Characteristics, Surgical Outcomes, and Recurrence
hosted by Dr. Lizzie Lee · StayCurrentMD
Cued at 0:27 · stops at 1:12 · press play
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
More about Currarino syndrome
same diagnosisOnly a few other public items share this diagnosis — nothing to add yet.
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026
Video
Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients
1 min · Published May 2026
Video
Tricuspid valve surgery in transposition of the great arteries with a systemic right ventricle
46 s · Published May 2026
What the experts said
A multicenter review examined over 200 sacrococcygeal teratoma cases comparing children with Currarino syndrome to those without it.
Currarino patients were almost always diagnosed after birth.
Tumors in Currarino patients are almost exclusively Altman type 4, buried deep in the pelvis.
Every tumor in the Currarino group was a mature one with no immature or malignant components at all.
Currarino-associated tumors were much smaller, around 3 centimeters instead of 8 centimeters.
Recurrence was almost nonexistent in Currarino cases and not significantly different from non-Currarino cases.
Currarino-associated sacrococcygeal teratomas behave incredibly well oncologically, suggesting potential for less aggressive long-term follow-up.